GRC, I have a few minutes to answer some of your questions regarding the parameters of the patents. Not taking time to edit this so excuse spelling typos.
Actually, your investigation of the specific constants and parameters should have answered your own questions.
Without disclosing trade secrets, I can offer the following information as to what is partially involved with the MDI-P technology:
An anode and cathode is placed at a very tightly guarded, and patented, side by side distance in their machine. The electro current that bounces in between the anode and the cathode, and interacts with the chlorine and oxygen, creates the MDI-P electrolized solution. The specific combination of oxygen and chlorine are patented, as is the specific width that the anode and the cathode are set. The specific width that the anode and cathode are set, is VERY IMPORTANT and again is PATENTED.
Medical Discoveries has had a potential competitor try to end run them and try to go around their patents, and MLSC quite enjoyed the fact that this gentleman's results actually produced bacteria growth. Again, the specific width at which the cathode and anode are placed gives the optimal antibacterial/antimicrobial advantage and is patented. Their superior results will not be able to be taken advantage of, or copied, or infringed on by ANY competitor. Much much money has been directed into patent protection for MLSC's technology, and they are in pursuit of still more patent protection.
MLSC just currently recieved another notice of allowance for the patent for thier solution, and once patent fees are paid, they will formally be issued this third patent.
MLSC were just recently selected for a privilaged display of their technology into the American Society for Microbiology conference that is to take place in Miami Beach, FLorida, May 4th through the 8th. They are very honored and excited to have been able to provide the abstracts of research required that enabled their being chosen for participation in this conference. MLSC management will not be in attendance, but rather the researchers from Albany will be representing their technology.
Also, in answer to your question as to whether commercialization for their first patent, (method for the treatment of antigen related infections of either cardiomyopathy and multiple sclerosis) is being sought after--the answer is no, not at this time. This isn't taking precendence as of this date.
Also, in answer to your question concerning the specific and limited ranges of this first patent (cardiomyopathy and multiple sclerosis), again, much money has been consumed for patent protection, and MLSC results for treatments of infections of either cardiomyopathy and multiple sclerosis are strictly and diligently protected and guarded.
They are currently participating in ongoing studies and are fine tuning their technology as well as exploring other horizons for application of thier technology.
You asked, What is the effect on the sterilization of going outside this range? Any ideas? No effect! I am happy to report--Has been fine tuned.
Hope this answers some of your questions!
Have a happy everyone,
Cindy |
